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DBackground: Patients undergoing transcatheter aortic valve replacement (TAVR), as compared with those
undergoing surgical aortic valve replacement (AVR), have higher postprocedural aortic regurgitation (AR),
associated with higher mortality. We hypothesized that reduced annular deformation is associated with higher
postprocedural AR and sought to assess incremental value of assessment of aortic annular deformation in
prediction of post-TAVR AR.
Methods: We included 87 patients with high-risk severe aortic stenosis (AS) (81  10 years, 54% men) who
underwent preprocedural echocardiography and contrast-enhanced (4-dimensional) multidetector computed
tomography (MDCT) of the aortic root, followed by TAVR (n¼ 55) or surgical AVR (n¼ 32). On MDCT, min-
imal/maximal annular circumference, circumferential deformation (maximum-minimum over cardiac cycle),
and eccentricity (largest/smallest diameter during systole) were calculated. Degree of commissural/annular cal-
cification was graded semiquantitatively (scale 1-3). Oversizing/undersizing of the prosthesis during TAVR was
assessed.
Results: Pre-AVR aortic valve area (0.6 0.1 vs 0.6 0.1 cm2), mean aortic valve gradient (46 14 vs 45 11
mm Hg), AR (1  0.8 vs 0.9  0.7), maximal annular circumference (8  1 vs 7.9  0.8 cm), annular defor-
mation (0.3  0.1 vs 0.3  0.1 cm), eccentricity (1.2  0.1 vs 1.2  0.1), commissural (2.1  0.6 vs 2 
0.7), and annular calcification scores (1.7  0.8 vs 1.7  0.8) were similar in TAVR and surgical AVR groups
(P¼ not significant). A higher proportion of patients hadmild AR in the TAVR than in the surgical AVR group
(58% vs 34%; P<.03). In TAVR patients, reduced annular deformation (P¼ .01) predicted postprocedural AR,
in addition to prosthesis undersizing (P ¼ .03) and higher annular calcification (P ¼ .03).
Conclusions: Residual post-TAVR AR is predicted by reduced aortic annular deformity, higher annular
calcification, and prosthesis undersizing. Pre-TAVR 4-dimensional annular assessment aids in prediction of
post-TAVR AR. (J Thorac Cardiovasc Surg 2014;147:1847-54)Video clip is available online.
Recent trials have established transcatheter aortic valve re-
placement (TAVR) as a viable alternative for patients with
severe, symptomatic aortic stenosis (AS) and high operative
risk.1-4 In addition, it has been recently demonstrated that
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The Journal of Thoracic and Carworse outcomes.4 Because transcatheter implantation is
performed without direct visualization of the device landing
zone, preprocedural and intraprocedural imaging is critical,5
for which multimodality imaging (angiography, transtho-
racic/transesophageal echocardiography [TEE], and multi-
detector computed tomography [MDCT]) is routinely
used.5 The procedural goal is secure, coaxial fit of the stent
valve at the aortic annulus and root. Recent studies have ex-
amined imaging-derived predictors of procedural complica-
tions and specifically post-TAVR AR.6-8
We sought to assess whether patients undergoing TAVR
had higher degree of postprocedural AR, compared to those
undergoing surgical aortic valve replacement (AVR). Al-
though it is known that aortic annulus geometry changes dur-
ing the cardiac cycle,6,9,10 most of the data are derived from
static images at a single cardiac phase. Recent advances
in software technology allow advanced time-resolved
3-dimensional computed tomographic (CT) reconstructions
(ie, 4-dimensional reconstructions), by integration and inter-
polation of multiple image sets along the cardiac cycle. Wediovascular Surgery c Volume 147, Number 6 1847
Abbreviations and Acronyms
AR ¼ aortic regurgitation
AS ¼ aortic stenosis
AVR ¼ aortic valve replacement
CT ¼ computed tomography
LVOT ¼ left ventricular outflow tract
MDCT ¼ multidetector computed tomography
TAVR ¼ transcatheter aortic valve replacement
TEE ¼ transesophageal echocardiography
VTI ¼ velocity time interval
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Dhypothesized that a detailed geometric analysis of such data
could provide insight into the impact of differences in aortic
annular deformability in patients with AS. In turn, such an
insight could improve our understanding of post-TAVRpara-
valvular AR.
METHODS
Eighty-seven consecutive patients with severe symptomatic AS, referred
for evaluation for surgical versus percutaneous valve replacement, were in-
cluded in this observational study. Severe AS was confirmed and severity
was graded according to established echocardiographic guidelines.11
Patients deemed to be at high surgical risk were included if they had under-
gone clinically indicated comprehensive echocardiography and contrast-
enhanced MDCT of the aortic root at our institution within 1 week of
each other. According to current protocols, we excluded patients with bicus-
pid aortic valvemorphology.1-4 Patientswith advanced renal insufficiency or
other contraindications to intravenous contrast dye were also excluded. The
final population consisted of high-risk patients with severe AS who under-
went either TAVR (n ¼ 55) or conventional surgery (n ¼ 32). Clinical,
demographic, and imaging data were collected. Surgical risk was assessed
and an additive EuroSCORE was calculated.12 This observational study
was approved by the institutional review board, with waiver of individual
informed consent.
Preprocedural Transthoracic Echocardiography
Surface echocardiograms were obtained using commercially available
systems (Siemens, Erlangen, Germany; General Electric, Milwaukee,
Wis; and Philips, Best, The Netherlands). Left ventricular ejection fraction
was calculated according to American Society of Echocardiography guide-
lines.13 Peak and mean transaortic valvular gradients were measured using
continuous wave Doppler in standard views. Velocity time integrals (VTI)
across the aortic valve (using continuous wave Doppler) and left ventricu-
lar outflow tract (LVOT; using pulsed wave Doppler) were recorded. LVOT
diameter was measured from the parasternal long-axis during midsystole
and LVOTareawas derived. Aortic valve areawas calculated using the con-
tinuity equation: (LVOT diameter2 3 0.786 3 LVOTVTI)/Aortic valveVTI.
Degree of ARwas recorded on a scale of I to IV, usingmultiple Doppler and
2-dimensional criteria. All measurements were performed according to
guidelines.11,14
MDCTAcquisition and Analysis
Image acquisition. All subjects were scanned on standard MDCT
scanner (Definition Dual Source/Definition Flash, Siemens Medical Solu-
tions, Erlangen, Germany; or Brilliance 256-slice, Philips Medical Sys-
tems, Best, The Netherlands) after administration of iodinated contrast
(80-100 mL of Ultravist 370) at 4 to 5 mL/s followed by 30 to 50 mL of
normal saline. Bolus tracking technique using a region of interest in the1848 The Journal of Thoracic and Cardiovascular Surascending aorta was used, and scanning (from the carina to themid left ven-
tricle) was initiated in the craniocaudal direction during a single inspiratory
breathhold. Spiral data were acquired with retrospective electrocardiogram
gating using the following parameters: gantry rotation time ¼ 270 to 330
ms; beam collimation ranging from 128 3 0.6 mm to 32 3 0.6 mm;
tube voltage ¼ 100 to 120 kVp; tube current adjusted per patient weight;
and beam pitch of 0.2 to 0.5. Electrocardiogram-based tube current modu-
lation was used for all patients, with maximum current turned on between
30% to 70% phases of the cardiac cycle (hence maintaining image quality
during the systolic phases). For the remaining phases, the current was re-
duced. Images were reconstructed during 10 phases of the cardiac cycle
with a section thickness of 0.75 mm. Radiation in the study sample
was<12 mSEV.
Image analysis. Advanced MDCT image processing was performed
using Ziostation PhyZiodynamics software (Qi Imaging, Redwood City,
Calif). Each volume of the 10-phase data set was deformably registered
to both neighboring phases, using a cyclic method whereby the first
and last series were considered neighbors. Subsequently, a noise reduc-
tion algorithm was applied followed by improvement in motion coher-
ence using interpolation of 4 additional phases between the original
phases based on the registered voxels. These first 2 steps resulted in
a newly generated data set consisting of 50 phases. To generate the
dynamic measurement data, the user activated a tool to define the aortic
annulus to calculate the circumference and area, or the tool could be used
to place 2 points to calculate a length. Aortic annular plane was defined
on a double oblique reconstruction at the level of the virtual basal ring, as
previously described.15,16 In cases of annular calcification, the annular
tracing excluded areas of calcification from the measurements. All data
was exported as .csv files and uploaded into Excel for statistical
processing.
For the current study, the following parameters were measured (Figure 1
and Videos 1 and 2): maximal and minimal aortic annular circumference,
delta annular circumference (maximum-minimum over the cardiac cycle,
representing the deformation of the annulus through the cardiac cycle),
maximal and minimal aortic annular area, delta annular area (maximum-
minimum over the cardiac cycle), largest and smallest diameters of the
aortic annulus (maximum and minimummeasurements for both), delta an-
nular diameters (maximum-minimum diameter over the cardiac cycle), and
eccentricity index (ratio of largest to smallest diameter at 40% systolic
phase). Using established valve circumference (72 mm for 23-mm and
82 mm for 26-mm prosthetic valve), percentage of prosthetic valve versus
aortic annulus oversizing (positive percentage) and undersizing (negative
percentage) was calculated using the following formula: (prosthetic valve
circumference/annular circumference  1)/100.7 Additionally, degree of
leaflet calcification was semiquantitatively assessed, using the following
grades: 1: single lesion<5 mm, 2: lesion>5 mm, or affecting 2 leaflets,
3: severe calcification affecting 3 leaflets. Similarly, the degree of aortic an-
nular calcification was assessed as follows: grade 1, 1 or several lesions<5
mm; grade 2, 2 to 3 lesions>5 mm; and grade 3,>3 lesions>5 mm.
Surgical AVR, TAVR, and Intraprocedural TEE
For the purpose of this study, all echocardiographic measurements were
remeasured by an experienced echocardiographer in a blindedmanner. Sur-
gical AVR was performed in a standard fashion under transesophageal
guidance and general anesthesia. TAVR implantation (using the Edwards
Sapien valve; Edwards Lifesciences, Irvine, Calif) was performed using
general anesthesia and intraprocedural TEE as described.5 Annular size
was reconfirmed using intraprocedural TEE on a zoomed long-axismidsys-
tolic frame (hinge point to hinge point). Prosthetic valve size selection was
performed as previously described5: 23-mm prosthesis for annuli measur-
ing 18 to 21 mm and 26-mm prosthesis for annuli measuring 22 to 25 mm.
By means of fluoroscopic and TEE guidance, the deployment of the pros-
thetic valve was ascertained, according to guidelines.17 Subsequently,
positioning of the valve was retrospectively assessed on long-axis TEEgery c June 2014
FIGURE 1. Four-dimensional multidetector computed tomographic
image of the aortic annulus in a patient with severe aortic stenosis demon-
strating various annular measurements including largest/smallest diameter,
circumference, and area.
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gram. A ratio of valve depth below the annulus to total prosthetic valve
length was measured in each patient. If the ratio was  60%, the device
was considered malpositioned, according to published data.6
In both groups, degree and location (paravalvular vs central) of postpro-
cedural ARwas again ascertained on a scale of I to IVusing multiple Dopp-
ler and 2-dimensional criteria, as described above. In addition, offline
measurement of vena contracta (for paravalvular AR) was made in all
patients.
Postprocedural Echocardiography
A postprocedural, predischarge echocardiogram was also performed in
all patients, (typically postprocedural day 2-3) in a manner similar toTABLE 1. Baseline clinical characteristics of the study population
Variable Total group (n ¼ 87) Surg
Age (y) 81  10
Male gender 47 (54%)
Hypertension 70 (80%)
Diabetes mellitus 29 (33%)
Myocardial infarction 18 (21%)
Stroke 22 (25%)
COPD 26 (30%)
Prior cardiac surgery 42 (48%)
Beta-blockers 58 (57%)
ACE inhibitors 40 (46%)
NYHA class (I-IV) 3  0.5
BUN (mg/dL) 23  8
Creatinine (mg/dL) 1  0.3
Additive EuroSCORE 13.0  1.8
AVR, Aortic valve replacement; TAVR, transcatheter aortic valve replacement; COPD
NYHA, New York Heart Association; BUN, blood urea nitrogen.
The Journal of Thoracic and Carpreprocedural echocardiography. Degree of AR (including paravalvular
AR) was ascertained on a scale of I to IV, according to guidelines using
multiple 2-dimensional, color and Doppler criteria.11,13,14 In addition,
offline measurement of vena contracta (for paravalvular AR) was made
in all patients.Statistical Analysis
All values presented are the mean  standard deviation for continuous
variables and percentage for categorical variables. Two independent sam-
ples test was used to compare continuous variables. The c2 test was used
for comparison of categoric variables. In addition, interobserver and intra-
observer (A.M. and M.D.) reproducibility of various MDCT parameters
(annular area and circumference) were measured using the Bland-
Altman method. Receiver operator characteristic curve analysis was per-
formed to test the association between dependent variable (post-TAVR
AR) and continuous variable (potential predictors). Univariable logistic re-
gression analysis was initially used to determine the association between
dependent variable (residual post-TAVR AR) and potential predictors.
Subsequently, predictors with a P value< .05 on univariable analysis
were entered into the multivariable model. All P values were 2 sided.
Data assembly statistical comparisons were performed with SPSS version
11.5 (SPSS Inc, Chicago, Ill).RESULTS
Baseline Characteristics
The baseline clinical and echocardiographic characteris-
tics of the total group, as well as the 2 subgroups, TAVR and
high-risk surgical AVR, are shown in Tables 1 and 2. All pa-
tients were symptomatic on maximally tolerated medical
therapy. No patient had post-CT scan nephrotoxicity requir-
ing dialysis. In all patients, the aortic valve disease was
predominantly AS. There were no patients with severe
mitral regurgitation. The baseline MDCT characteristics
are shown in Table 3. Intraobserver (A.M.) and interob-
server (M.D.) reproducibility of minimal and maximal
annular area was assessed using the Bland-Altman method
(Figure 2, A and B).ical AVR (n ¼ 32) TAVR (n ¼ 55) P value
84  6 80  11 .06
19 (59%) 28 (51%) .3
27 (84%) 43 (78%) .3
10 (31%) 19 (35%) .5
7 (22%) 11 (20%) .5
13 (41%) 9 (16%) .01
11 (36%) 15 (27%) .3
17 (53%) 25 (45%) .5
25 (86%) 33 (60%) .02
11 (40%) 29 (53%) .2
3  0.6 3  0.5 .9
22  7 24  9 .5
1.02  0.6 1.01  0.31 .5
13.3  1.7 12.8  1.8 .2
, chronic obstructive pulmonary disease; ACE, angiotensin-converting enzyme;
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TABLE 2. Baseline echocardiographic characteristics of the study population
Variable Total group (n ¼ 87) Surgical AVR group (n ¼ 32) TAVR group (n ¼ 55) P value
LV ejection fraction (%) 51  13 48  14 53  13 .1
LV end-diastolic dimension (cm) 4.7  0.9 4.8  1.1 4.6  0.8 .4
LV end-systolic dimension (cm) 3.3  1 3.6  1.3 3.2  1 .08
AV peak gradient (mm Hg) 78  22 74  18 79  24 .3
AV mean gradient (mm Hg) 46  13 45  11 46  14 .6
AV area (cm2) 0.6  0.1 0.62  0.1 0.63  0.1 .5
LVoutflow tract diameter (cm) 1.96  0.2 2.03  0.1 1.92  0.2 .02
AR (I-IVþ) 1.0  0.7 0.86  0.7 1.1  0.8 .2
MR (I-IVþ) 1.3  0.8 1.4  0.7 1.2  0.8 .2
TR (I-IVþ) 1.2  0.9 1.2  0.9 1.2  0.9 .9
RV systolic pressure (mm Hg) 43  17 42  15 44  17 .5
AVR, Aortic valve replacement; TAVR, transcatheter aortic valve replacement; AV, aortic valve; LV, left ventricular; AR, aortic regurgitation;MR, mitral regurgitation; TR, tricuspid
regurgitation; RV, right ventricular.
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Groups
There were no intraprocedural deaths in either group. The
predischarge echocardiographic findings are shown in
Table 4. A significantly higher proportion of patients had
postprocedural paravalvular AR (mild or more) in the
TAVR than in the surgical AVR group (58% vs 34%;
P< .03). Within the surgical AVR group, 2 patients had
2þ residual AR; the rest had mild (1þ) AR. On the other
hand, moderate or higher degree of postprocedural para-
valvular ARwas seen in 5 (9%) patients in the TAVR group.
The paravalvular aortic regurgitant vena contracta was sig-
nificantly higher in the TAVR group than in the surgical
AVR group (2 0.16 vs 1 1.3; P¼ .03). Otherwise, there
were no significant differences in the 2 subgroups.TABLE 3. Baseline MDCT characteristics of the study population
Variable Total group (n ¼ 87)
Minimal annular circumference (mm) 77  9
Maximal annular circumference (mm) 80  9
Deformation in annular circumference during
cardiac cycle (mm)
3  1
Minimal annular area (mm2) 445  102
Maximal annular area (mm2) 482  111
Deformation in annular area during cardiac
cycle (mm2)
38  17
Minimal largest diameter (mm) 25  3
Maximal largest diameter (mm) 26  3
Deformation in largest diameter during
cardiac cycle (mm)
1.2  0.5
Minimal smallest diameter (mm) 20  3
Maximal smallest diameter (mm) 21  3
Deformation in smallest diameter during
cardiac cycle (mm)
1.2  0.5
Eccentricity index 1.2  0.1
Commissural calcification 2.1  0.7
Annular calcification 1.7  0.7
MDCT, Multidetector computed tomography; AVR, aortic valve replacement; TAVR, trans
1850 The Journal of Thoracic and Cardiovascular SurAnalysis of the TAVR Group
We further explored the imaging characteristics of the
TAVR group (n¼ 55), separated into 2 subgroups on the ba-
sis of degree of paravalvular AR: (1) trivial AR, n¼ 23) and
(2) at least mild AR (n ¼ 32). The findings are shown in
Table 5. There was a significantly higher degree of annular
(but not leaflet) calcification in the nontrivial AR group as
compared with the trivial AR group. The deformation of
the annular circumference and area were significantly lower
(suggesting a ‘‘stiffer’’ annulus) in the mild or more AR
group as compared with the trivial AR group. A signifi-
cantly higher proportion of patients in the nontrivial AR
group had an undersized prosthetic valve, defined as a neg-
ative prosthetic valve to annular circumference ratio (74%
vs 33%; P ¼.004). The eccentricity index was similar inSurgical AVR group (n ¼ 32) TAVR group (n ¼ 55) P value
76  8 77  10 .5
79  8 80  10 .5
3  1 3  1 .7
435  89 450  109 .5
472  98 488  118 .5
37  17 38  17 .9
25  3 25  3 .9
26  3 26  3 .8
1.1  0.6 1.3  0.5 .2
20  3 20  4 .8
22  3 21  3 .8
1.2  0.7 1.2  0.4 .8
1.2  0.1 1.2  0.1 .9
2.0  0.7 2.1  0.6 .6
1.7  0.8 1.7  0.8 .9
catheter aortic valve replacement.
gery c June 2014
FIGURE 2. A, Bland-Altman graphs showing intraobserver variability for maximal andminimal aortic annular area (mm2). B, Bland-Altman graphs show-
ing interobserver variability for maximal and minimal aortic annular area (mm2). SD, Standard deviation.
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2 subgroups. No patient had a malpositioned prosthesis, and
none required a valve-in-valve procedure. On receiver oper-
ator characteristic curve analysis, the area under the curve
for degree of annular circumferential deformation predict-
ing mild or greater post-TAVR AR was significant (0.72;
P<.001; Figure 3). A cutoff value of less than 3 mm for an-
nular circumferential deformation had a sensitivity of 74%
and specificity of 72% for prediction of nontrivial post-
TAVR AR. Similarly, the area under the curve for degree
of annular area deformation was also significant (0.69;
P<.001).TABLE 4. Postprocedural echocardiographic characteristics of the study
Variable Total group (n ¼ 87) Surg
LV ejection fraction (%) 52  11
AV mean gradient (mm Hg) 22  11
AV peak gradient (mm Hg) 11  6
Aortic regurgitant vena contracta 0.19  0.2
Patients with more than trivial AR 34 (39%)
MR (I-IV) 0.9  0.6
TR (I-IV) 1.2  0.8
RV systolic pressure (mm Hg) 40  12
AVR, Aortic valve replacement; TAVR, transcatheter aortic valve replacement; LV, left ventri
regurgitation; RV, right ventricular.
The Journal of Thoracic and CarSubsequently, we performed logistic regression analysis
to test for predictors of nontrivial AR in the TAVR group.
The results are shown in Table 6. On multivariable analysis,
in addition to higher annular calcification and prosthesis
undersizing, reduced annular deformation remained inde-
pendent predictors of nontrivial AR. The results were sim-
ilar when deformation of annular area was substituted for
annular circumference. In the study population, only 5 pa-
tients in the TAVR group had moderate or more residual
AR. Although the deformation of annular area during the
cardiac cycle did not reach statistical significance, it was in-
deed lower (suggesting a trend toward a stiffer annulus) inpopulation
ical AVR group (n ¼ 32) TAVR group (n ¼ 55) P value
49  12 53  11 .2
11  6 11  5 .9
23  11 22  11 .9
0.1  0.1 0.2  0.2 .03
11 (34%) 32 (58%) .03
1  0.8 0.9  0.5 .4
1.2  0.9 1.2  0.1 .9
40  11 40  12 .9
cular; AV, aortic valve; AR, aortic regurgitation;MR, mitral regurgitation; TR, tricuspid
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TABLE 5. Clinical and imaging characteristics of the TAVR group
Variable Trivial AR (n ¼ 23) More than trivial AR (n ¼ 32) P value
Age (y) 79  11 80  11 .9
Gender (%) 12 (52%) 16 (50%) .5
LV ejection fraction (%) 53  13 52  14 .9
Mean AV gradient (mm Hg) 48  17 45  12 .5
AV area (cm2) 0.63  0.1 0.64  0.13 .7
LVoutflow tract (cm) 1.9  0.2 1.9  0.2 .8
RV systolic pressure (mm Hg) 42  15 46  19 .4
Commissural calcification 2  0.5 2.2  0.7 .2
Annular calcification 1.4  0.6 1.8  0.02 .02
Deformation in annular circumference during cardiac cycle (mm) 3.6  1.3 2.6  0.8 .001
Deformation in annular area during cardiac cycle (mm2) 46  21 32  10 .003
Deformation in largest diameter during cardiac cycle (mm) 1.4  0.5 1.1  0.4 .05
Deformation in smallest diameter during cardiac cycle (mm) 1.2  0.5 1.2  0.4 .6
Prosthetic valve to annular circumference sizing ratio (%) 0.03  7 7  10 .007
Eccentricity index 1.3  0.2 1.2  0.1 .3
Prosthetic valve position ratio 0.33  0.1 0.34  0.1 .7
TAVR, Transcatheter aortic valve replacement; AR, aortic regurgitation; LV, left ventricular; AV, aortic valve; RV, right ventricular.
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lesser AR group (32  9 mm2 vs 38  9 mm2; P ¼ .3).DISCUSSION
In the current study, we demonstrate that patients under-
going TAVR had a higher degree of paravalvular AR than
did those undergoing surgical AVR.We demonstrate that re-
duced deformation (suggesting reduced compliance) of an-
nular circumference was a predictor of nontrivial AR after
TAVR. This association was independent of established pre-
dictors of post-TAVR AR (prosthetic valve undersizing and
annular calcification, which have been previously de-
scribed).7,8,18 The results were similar when deformation
of annular area during the cardiac cycle was substituted
for deformation of annular circumference. These results,FIGURE 3. Receiver operator characteristic curve analysis showing the
area under the curve for ability of aortic annular circumferential deform-
ability to predict mild or more aortic regurgitation in patients undergoing
transcatheter aortic valve replacement.
1852 The Journal of Thoracic and Cardiovascular Surobtained with an advanced time-resolved (4-dimensional)
analysis, provide important insights into the interaction be-
tween stent/valve and annulus and demonstrate the impact
of device landing zone deformability on procedural out-
comes. In the current study, neither aortic annular eccentric-
ity nor position of valvular prosthesis vis-a-vis the annulus
was associated with post-procedural AR.
The study population was typical of those undergoing
evaluation followed by high-riskAVR (either TAVRor surgi-
cal). The study populationwas old with a relatively high pro-
portion of conventional risk factors and a high EuroSCORE.
Other than difference in the degree of postprocedural AR,
therewere no significant differences in the clinical and imag-
ing characteristics of patients who underwent surgical AVR
versus TAVR. The proportion of postprocedural AR in the
surgical AVR group was higher than what has been reported
previously; this is likely because of older population in the
current study with higher degree of annular calcification.19
However, only 2 patients had moderate (2þ) paravalvular
aortic valve leak; the rest had mild (1þ) residual AR.
During surgical AVR, sewing of the annulus on the valve
ring forces the annulus into the shape required for a tight fit.
In contrast, during TAVR, device deployment is associated
with incompletely understood interaction between the
expanding stent valve and the compliance of the landing
zone. Not surprisingly, our data and prior studies demon-
strate a higher proportion of AR in high-risk patients under-
going TAVR versus surgical AVR, despite similar baseline
and imaging characteristics.4 Although, traditionally, mod-
erate or severe AR has been thought to be associated worse
outcomes, the presence of mild or more post-TAVR AR has
assumed increased clinical significance since it was re-
cently associated with worse outcomes.4
Post-TAVR AR is very likely related to an undersized
stent valve or focal incomplete coaptation secondary togery c June 2014
TABLE 6. Univariable and multivariable logistic regression analysis
evaluating the predictors of postprocedural aortic insufficiency in
the TAVR group
Variable
Univariable Multivariable
Wald
statistic P value
Wald
statistic P value
Age 0.006 .9
Gender 0.03 .9
Hypertension 0.42 .5
Diabetes mellitus 0.4 .5
Myocardial infarction 0.9 .3
Beta-blockers 0.2 .7
Preprocedural ejection fraction 0.005 .9
LV end-diastolic dimension 1.17 .3
LV end-systolic dimension 0.05 .8
Diastolic dysfunction 0.69 .4
Mean AV gradient 0.56 .5
AV area 1.11 .6
Preprocedure AR 2.9 .09
Commissural calcification 1.12 .3
Annular calcification 4.9 .03 4.4 .03
Eccentricity index 1.12 .3
Deformation of annular
circumference during cardiac
cycle
8.99 .003 6.6 .01
Valve prosthesis: size 23 or 26 1.7 .2
Prosthesis position ratio 0.14 .7
Prosthesis to annular
circumference sizing ratio
6.5 .01 4.3 .03
Postprocedural ejection fraction 0.02 .9
When deformation of annular area was entered into the model instead of circumfer-
ence, the results were similar. TAVR, Transcatheter aortic valve replacement; LV, left
ventricular; AV, aortic valve; AR, aortic regurgitation.
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(owing to reduced deformation and/or annular calcification).
An expanding literature demonstrates that undersizing can
be avoided with careful preprocedural measurements.7,8 In
contrast, prediction of focal coaptation is more difficult, in
particular because of the complex and dynamic shape
of the annulus and concomitant annular calcification.
Multiple prior studies have demonstrated the oval shape
of the annulus,16,20,21 and recent studies have shown that
the aortic annulus geometry changes during the cardiac
cycle.6,9,10
Multiple studieshave examined imaging-derivedpredictors
of procedural complications and specifically postprocedural
AR.6-8 They have demonstrated that annular calcification
and valve undersizing are important contributors of residual
post-TAVRAR. However, none of these studies has systemat-
ically evaluated dynamic deformation of the aortic annulus.
Recent advances in software technology allow advanced
high temporal resolution time-resolved 3-dimensional CT re-
construction (ie, 4-dimensional reconstruction) by integration
and interpolation of multiple image sets along the cardiacThe Journal of Thoracic and Carcycle. With this approach, our results, for the first time, dem-
onstrate that annular deformability has an impact on postpro-
cedural AR. The differences in annular deformity in patients
with significant versus nonsignificant post-TAVR AR were
subtle, likely because of the homogeneity of the study popula-
tion (all were older high-risk AS patients). To demonstrate
differences in deformability, we need to study patients with
a wider spectrum of age and disease severity to establish
thresholds of normal values of deformation of the aortic annu-
lus. Once the thresholds are established, they could be used to
identify patients who have a stiffer annulus (less deformabil-
ity), which could help predict post-TAVRAR.Another poten-
tial utility is probably to help design future stents that aremore
malleable and confirm to the dynamic nature of the annulus.
Limitations
This is a small observational study of patients who were
able to have a contrast-enhanced CT scan followed by
AVR. Hence, there is insufficient power to evaluate hard out-
comes. As an initial step, we wanted to ascertain that there
indeed was a higher prevalence of AR in the TAVR as com-
pared with the surgical group. As a result, we report data on
both surgical and TAVR groups, followed by a detailed anal-
ysis of the TAVR group. The concept of 3-dimensional as-
sessment of the aortic annulus is a rapidly evolving one.
When the current study population was imaged, the standard
of care was to use 2-dimensional echocardiography (ob-
tained on surface echocardiography and subsequently con-
firmed by TEE in the catheterization laboratory) to obtain
annular measurements and decide on appropriate valve
size. It is only recently that 3-dimensional measurements
have becomemore prevalent. As a result, thosewere not uni-
formly available and, hence, not reported. Annular calcifica-
tion was performed semiquantitatively, rather a calcium
score (which is not validated in contrast-enhanced studies).
In older TAVR patients, iodinated contrast is associated
with increased risk of nephrotoxicity. However, in the
current study, no patient had significant post-CT scan neph-
rotoxicity. Although MDCT is also associated with signifi-
cant radiation exposure, the risks of long-term deleterious
effects of radiation are of lesser concern in older TAVR pa-
tients. As a result, a reasonable compromise would be to
avoid radiation dose modulation to maintain optimal image
quality. Still, for the MDCT community, it is important to
continue to work on minimizing radiation exposure. With
availability of newer imaging techniques, the concept of ag-
gressive radiation reduction is rapidly evolving. We divided
postprocedural AR into trivial and nontrivial, with nontrivial
defined as AR equal to or greater than mild. This definition
appears controversial, inasmuch as current clinical practice
typically differentiates between mild and significant (ie,
IIIþ) AR. However, this may not apply to TAVR, inas-
much as recent studies demonstrate that presence of nontriv-
ial, post-TAVRARwas associatedwith increasedmortality.4diovascular Surgery c Volume 147, Number 6 1853
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DCONCLUSIONS
In high-risk symptomatic patients with severe AS, there
is a higher incidence of postprocedural nontrivial AR in
the TAVR group as compared with the surgical AVR group.
Using 4-dimensional MDCT imaging, we demonstrate that
reduced deformation of annular circumference during the
cardiac cycle, in addition to prosthesis undersizing and an-
nular calcification, is an independent predictor of postpro-
cedural AR. These results provide important insights into
the interaction between the stent/valve and the aortic annu-
lus and demonstrate the impact of device landing zone
deformability on TAVR outcomes.
We thank Richard Bennett of Qi systems, Redwood City,
California, for supplying the Ziostation Physiodynamics work
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